CLINICAL_TRIALS trial_result · 2016-12-15

Clinical Trial Update: Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia [Phase 2]

Phase 2 study of lenalidomide (Revlimid) as consolidation therapy in chronic lymphocytic leukemia was terminated; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Thomas Kipps | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2016-12-15